Cornelis D de Kroon

10PUBLICATIONS
70CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)SociolinguisticsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 13, 2025
The Prognostic Value of FOXL2 Mutant Circulating Tumor DNA in Adult Granulosa Cell Tumor Patients.

Geertruid J Brink, Nizar Hami, Hans W Nijman

|Nov 27, 2024
Response to Systemic Therapies in Patient-Derived Cell Lines from Primary and Recurrent Adult Granulosa Cell Tumors.

Geertruid J Brink, Nizar Hami, Sander Mertens

|Oct 25, 2024
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial.

Janice S Kwon, Helen McTaggart-Cowan, Sarah E Ferguson

|Oct 07, 2024
Clinical and Molecular Characteristics of High-Risk, Recurrent, or Metastatic Endometrial Cancer That Is Human Epidermal Growth Factor Receptor 2-Low.

Dione van Dijk, Lisa Vermij, Alicia León-Castillo

|Oct 01, 2024
Sexual Health and Quality of Life in Patients With Low-Risk Early-Stage Cervical Cancer: Results From GCIG/CCTG CX.5/SHAPE Trial Comparing Simple Versus Radical Hysterectomy.

Sarah E Ferguson, Lori A Brotto, Janice Kwon

|Aug 23, 2021
Response to Nahshon and Lavie.

Cornelis D de Kroon, Marthe M de Jonge, Tjalling Bosse

Pageof 2

Frequent Collaborators

3 joint publications

Jurgen M J Piek

3 joint publications

Hans W Nijman

2 joint publications

Ronald P Zweemer

2 joint publications

Christine A R Lok